About LizarBio Therapeutics

LizarBio Therapeutics is developing the first of its kind plataform to produce any cell type in the body at industrial scale (>100L). By reimagining cell culture media from the ground up, we have developed negligible-cost media to cultivate and differentiate pluripotent stem cells for therapeutic applications. Currently, we are developing two cellulat therapies focused on two key areas, namely: cardiology and neurology.

Company Highlights
Year Founded

2013

icon-altEmployees

5

Location (HQ)

BRA

Since Last Funding

2 years 6 months

Monthly Website Visitors

1.4K

icon-altTotal Investment Amt

$1.7M

Last Funding Round

Seed

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology

Life Science

Biotechnology Research